Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2022 Mar 29;113(3):542–551. doi: 10.1016/j.ijrobp.2022.03.007

Table 3.

Multivariable Analyses for the Combined Study Populations of NSABP B-40 and B-41 Evaluating the Association of Regional Nodal Irradiation with Local-regional Recurrence, Distant Recurrence, Disease-free Survival, and Overall Survival

LRR DR DFS OS
Variables HR P value HR P value HR P value HR P value
RNI 0·79 0·299 0·97 0·808 0·92 0·496 0·86 0·306
Age 0·98 0·069 0·99 0·045 0·99 0·047 0·99 0·274
Tumor subtype <0·001 <0·001 <0·001 <0·001
     HR+/HER2− 1·94 0·023 1·12 0·523 1·29 0·101 0·91 0·691
     TN vs HR+/HER2− 3·30 <0·001 1·88 <0·001 2·01 <0·001 2·24 <0·001
Breast pCR 0·48 0·008 0·46 <0·001 0·56 <0·001 0·45 <0·001
Axillary pCR 0·39 <0·001 0·30 <0·001 0·32 <0·001 0·23 <0·001
Clinical node positivity NS NS 1·41 0·014 NS NS NS NS
     Grade NS 0·011 0·004 0·001
     Grade 2 vs 1 NS NS 1·99 0·080 2·22 0·022 1·98 0·144
     Grade 3 vs 1 NS NS 2·66 0·014 2·72 0·004 3·32 0·011
Clinical tumor size NS NS NS NS 1·11 <0·001 1·11 <0·001

Abbreviations: LRR, local-regional recurrence; DR, distant recurrence; DFS, disease-free survival; OS, overall survival; pCR, pathological complete response; RNI, regional nodal irradiation; TN, triple negative; NS, not significant